Expresión proteica de PD-L1 y datos clínico-patológicos en una cohorte de 53 pacientes con carcinoma de pulmón de célula no pequeña (CPCNP) operados. Concordancia entre clones (22C3 y 28-8) y entre observadores. Correlación y valor pronóstico de datos clínico-patológicos

Esteban-Rodríguez, Isabel; Ruiz Bravo-Burguillos, Elena; Rosas, Rocio; Losantos, Itsaso; Rodríguez-Antolín, Carlos; Castro, Javier de.
Rev. esp. patol ; 53(1): 10-18, ene.-mar. 2020. ilus, tab, graf
Artículo en Español | IBECS (España) | ID: ibc-195571

Documentos relacionados

  1. Proteomics: A new dimension to decode small cell lung cancer.
  2. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
  3. Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease.
  4. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.
  5. Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC).
  6. Killing SCLC: insights into how to target a shapeshifting tumor.
  7. Potential subtype-specific therapeutic approaches in small cell lung cancer.
  8. Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis.
  9. Redefining the role of surgery in early small-cell lung cancer.
  10. Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer.